The differential IL-6 expression observed across CRC cell lines with distinct genetic backgrounds underscores the possible influence of tumor mutational landscape on cytokine-mediated inflammatory responses, consistent with evidence implicating tumor suppressor gene mutation burden in cancer susceptibility and progression (Ning et al., 2023). This evidence concerns the gene IL6 and neoplasm.